Search - tctmd.com

Displaying 681 - 700 of 4251

Sort: Relevancy | Date

News Conference News ACC 2016

Toker’s Paradox? Marijuana Users Face Lower Short-Term Risks After Acute MI, Study Hints

Todd Neale

April 11, 2016

News Daily News

FDA Approves Impella Left-Ventricular Heart Pumps for Cardiogenic Shock

Michael O'Riordan

April 08, 2016

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Shelley Wood

April 08, 2016

News Conference News ACC 2016

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

Michael O'Riordan

April 07, 2016

News Industry News

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

April 07, 2016

Presentation

Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR

Presenter: G. Michael Deeb

April 06, 2016

News Conference News ACC 2016

Choosing Radial Over Femoral: Single-Center Study Tackles Questions of When and Why

Yael L. Maxwell

April 06, 2016

News Conference News ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

L.A. McKeown

April 04, 2016

News Industry News

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

April 04, 2016

Presentation ACC 2016

Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients with Aortic Stenosis

Presenter: Craig R. Smith

April 03, 2016

News Conference News ACC 2016

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Shelley Wood

April 03, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

Presentation ACC 2016

Relationship Between Procedure Volume and Outcome for Transcatheter Aortic Valve Replacement in U.S. Clinical Practice: Insights from the STS-ACC TVT Registry

Presenter: John D. Carroll

April 03, 2016

Presentation ACC 2016

3-Year Results From the CoreValve US Pivotal High Risk Randomized Trial Comparing Self-Expanding Transcatheter and Surgical Aortic Valves

Presenter: Michael Deeb

April 03, 2016

News Conference News ACC 2016

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

Caitlin E. Cox

April 02, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

Presentation CHIP Florida 2016

PCI of High Risk Patients Under Hemodynamic Support: For Whom and with What?

Presenter: Jeffrey W. Moses

April 01, 2016

News Daily News

Minimally Invasive Mitral Valve Surgery Gives Good Outcomes Without Increasing Costs

Todd Neale

April 01, 2016

News Industry News

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

April 01, 2016

News Daily News

Cirugía de válvula mitral mínimamente invasiva da buenos resultados sin aumentar los costos

Todd Neale

April 01, 2016

Advertisement

Toker’s Paradox? Marijuana Users Face Lower Short-Term Risks After Acute MI, Study Hints

FDA Approves Impella Left-Ventricular Heart Pumps for Cardiogenic Shock

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR

Choosing Radial Over Femoral: Single-Center Study Tackles Questions of When and Why

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients with Aortic Stenosis

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Relationship Between Procedure Volume and Outcome for Transcatheter Aortic Valve Replacement in U.S. Clinical Practice: Insights from the STS-ACC TVT Registry

3-Year Results From the CoreValve US Pivotal High Risk Randomized Trial Comparing Self-Expanding Transcatheter and Surgical Aortic Valves

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

PCI of High Risk Patients Under Hemodynamic Support: For Whom and with What?

Minimally Invasive Mitral Valve Surgery Gives Good Outcomes Without Increasing Costs

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

Cirugía de válvula mitral mínimamente invasiva da buenos resultados sin aumentar los costos

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content